Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
2002 1
2004 1
2005 3
2006 2
2007 1
2008 1
2011 2
2012 1
2013 1
2014 1
2016 1
2019 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

16 results
Results by year
Filters applied: . Clear all
Page 1
Clinical determinants of plasma cardiac biomarkers in patients with stable chest pain.
Bing R, Henderson J, Hunter A, Williams MC, Moss AJ, Shah ASV, McAllister DA, Dweck MR, Newby DE, Mills NL, Adamson PD. Bing R, et al. Heart. 2019 Nov;105(22):1748-1754. doi: 10.1136/heartjnl-2019-314892. Epub 2019 Jun 1. Heart. 2019. PMID: 31154425 Free PMC article. Clinical Trial.
We aimed to establish clinical and cardiac determinants of these biomarkers. METHODS: This was a prespecified substudy from the randomised Scottish Computed Tomography of the Heart trial, which enrolled patients 18-75 years with suspected stable angina betwee …
We aimed to establish clinical and cardiac determinants of these biomarkers. METHODS: This was a prespecified substudy from the rando …
B-type natriuretic peptide levels in patients in the emergency department with possible heart failure and previous stable angina pectoris and/or healed myocardial infarction.
McCord J, Nowak RM, Jacobsen G, Sallach JA, Wu AH, Perez A, Omland T, Knudsen CW, Westheim A, Duc P, Steg PG, Hollander JE, Herrmann HC, Storrow AB, Abraham WT, Lamba S, McCullough PA, Maisel A. McCord J, et al. Am J Cardiol. 2005 Nov 15;96(10):1370-3. doi: 10.1016/j.amjcard.2005.07.040. Epub 2005 Sep 23. Am J Cardiol. 2005. PMID: 16275180 Clinical Trial.
We examined the relation between B-type natriuretic peptide (BNP) levels and a history of stable angina pectoris and/or healed myocardial infarction in 1,240 patients who were evaluated in the emergency department for possible heart failure. In …
We examined the relation between B-type natriuretic peptide (BNP) levels and a history of stable angina pectoris and/or …
Natriuretic peptides in unstable coronary artery disease.
Jernberg T, James S, Lindahl B, Johnston N, Stridsberg M, Venge P, Wallentin L. Jernberg T, et al. Eur Heart J. 2004 Sep;25(17):1486-93. doi: 10.1016/j.ehj.2004.06.017. Eur Heart J. 2004. PMID: 15342167 Review.
Patients with unstable coronary artery disease (CAD), i.e., unstable angina or non-ST-elevation myocardial infarction, vary widely in clinical presentation, prognosis and response to treatment. ...This review focuses on the emerging role of natriure
Patients with unstable coronary artery disease (CAD), i.e., unstable angina or non-ST-elevation myocardial infar …
Emerging cardiac markers in coronary disease: role of brain natriuretic peptide and other biomarkers.
Palazzuoli A, Iovine F, Gallotta M, Nuti R. Palazzuoli A, et al. Minerva Cardioangiol. 2007 Aug;55(4):491-6. Minerva Cardioangiol. 2007. PMID: 17653025 Review.
Brain natriuretic peptides (BNP and pro-BNP) represent useful biomarkers in heart failure diagnosis and risk stratification; more recently their clinical use has been applied to acute coronary syndrome with and without ST segment elevation. ...W …
Brain natriuretic peptides (BNP and pro-BNP) represent useful biomarkers in heart failure diagnosis and risk str …
Natriuretic peptides in acute chest pain and acute coronary syndrome: from pathophysiology to clinical and prognostic applications.
Aspromonte N, Di Fusco SA, Latini R, Cruz DN, Masson S, Tubaro M, Palazzuoli A. Aspromonte N, et al. Coron Artery Dis. 2013 Jan;24(1):33-9. doi: 10.1097/MCA.0b013e32835b6741. Coron Artery Dis. 2013. PMID: 23164752 Review.
BACKGROUND: Plasma levels of natriuretic peptides (NPs) appear to have an important prognostic value in many clinical settings including coronary artery disease and provide additional information about cardiovascular risk. ...CONCLUSION: Althoug …
BACKGROUND: Plasma levels of natriuretic peptides (NPs) appear to have an important prognostic value in many clinical settings …
Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18.
Morrow DA, Sabatine MS, Brennan ML, de Lemos JA, Murphy SA, Ruff CT, Rifai N, Cannon CP, Hazen SL. Morrow DA, et al. Eur Heart J. 2008 May;29(9):1096-102. doi: 10.1093/eurheartj/ehn071. Epub 2008 Mar 12. Eur Heart J. 2008. PMID: 18339606 Free PMC article. Clinical Trial.
AIMS: We investigated the prognostic performance of myeloperoxidase (MPO), and soluble CD40 ligand (sCD40L) along with B-type natriuretic peptide (BNP), high-sensitivity C-reactive protein (hsCRP), and cardiac troponin I (cTnI) for non-fatal recurrent ischaemic even …
AIMS: We investigated the prognostic performance of myeloperoxidase (MPO), and soluble CD40 ligand (sCD40L) along with B-type natriuretic
Relationship and prognostic importance of thyroid hormone and N-terminal pro-B-Type natriuretic peptide for patients after acute coronary syndromes: a longitudinal observational study.
Brozaitiene J, Mickuviene N, Podlipskyte A, Burkauskas J, Bunevicius R. Brozaitiene J, et al. BMC Cardiovasc Disord. 2016 Feb 18;16:45. doi: 10.1186/s12872-016-0226-2. BMC Cardiovasc Disord. 2016. PMID: 26892923 Free PMC article. Clinical Trial.
BACKGROUND: Altered thyroid function and increased rates of N-terminal pro-B-Type natriuretic peptide (NT-pro-BNP) are highly prevalent in coronary artery disease (CAD) patients with heart failure, and are associated with unfavorable prog …
BACKGROUND: Altered thyroid function and increased rates of N-terminal pro-B-Type natriuretic peptide (NT-pro-BNP) are highly prevale …
Relation of coronary atherosclerosis determined by electron beam computed tomography and plasma levels of n-terminal pro-brain natriuretic peptide in a multiethnic population-based sample (the Dallas Heart Study).
Abdullah SM, Khera A, Das SR, Stanek HG, Canham RM, Chung AK, Morrow DA, Drazner MH, McGuire DK, de Lemos JA. Abdullah SM, et al. Am J Cardiol. 2005 Nov 1;96(9):1284-9. doi: 10.1016/j.amjcard.2005.06.073. Epub 2005 Sep 9. Am J Cardiol. 2005. PMID: 16253599
Elevated plasma levels of B-type natriuretic peptide (BNP) and N-terminal pro-BNP (NT-pro-BNP) are seen in the setting of cardiac ischemia and are associated with adverse outcomes in patients with coronary artery disease. The mechanisms leading …
Elevated plasma levels of B-type natriuretic peptide (BNP) and N-terminal pro-BNP (NT-pro-BNP) are seen in the setting of cardiac
[Asymptomatic ischemic heart dysfunction, echocardiographic changes and NT-proBNP during 2-years observation].
Skrzypek A, Nessler J. Skrzypek A, et al. Przegl Lek. 2014;71(7):378-83. Przegl Lek. 2014. PMID: 25338333 Clinical Trial. Polish.
Analysis of echocardiographic parameters in patients with stable angina pectoris without symptoms of heart failure and their changes in two years time 2. ...In patients with stable angina pectoris without symptoms of heart failu
Analysis of echocardiographic parameters in patients with stable angina pectoris without symptoms of heart failure
B-type natriuretic peptide and long-term survival in patients with stable coronary artery disease.
Omland T, Richards AM, Wergeland R, Vik-Mo H. Omland T, et al. Am J Cardiol. 2005 Jan 1;95(1):24-8. doi: 10.1016/j.amjcard.2004.08.058. Am J Cardiol. 2005. PMID: 15619389
Circulating B-type natriuretic peptide (BNP) is a strong predictor of survival in patients with acute coronary syndromes and in patients with congestive heart failure. ...We studied 186 patients with stable angina pectoris and angiographi …
Circulating B-type natriuretic peptide (BNP) is a strong predictor of survival in patients with acute coronary syndromes and i …
16 results
Jump to page
Feedback